Hologic Stock Today

HOLX Stock  USD 74.75  0.19  0.25%   

Performance

Good

 
Weak
 
Strong

Odds Of Distress

Tiny

 
High
 
Low
Hologic is trading at 74.75 as of the 5th of January 2026; that is 0.25 percent increase since the beginning of the trading day. The stock's open price was 74.56. Hologic has a very small chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Note, on October 3, 2025, Representative Ro Khanna of US Congress acquired $15k to $50k worth of Hologic's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
21st of June 1990
Category
Healthcare
Classification
Health Care
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. The company has 223.07 M outstanding shares of which 3.67 M shares are currently shorted by private and institutional investors with about 1.24 trading days to cover. More on Hologic

Moving together with Hologic Stock

  0.78DHR DanaherPairCorr

Moving against Hologic Stock

  0.69GOOD Gladstone CommercialPairCorr
  0.66OM Outset MedicalPairCorr
  0.66T ATT IncPairCorr
  0.52HPQ HP IncPairCorr
  0.5SLMNP A SchulmanPairCorr
  0.45PG Procter GamblePairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Hologic Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Chairman, CEO and PresStephen MacMillan
Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, SP 500 Index, NASDAQ Composite Total, NASDAQ Health Care, Obamacare Repeal, SRI Sustainable Growth, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal Testing
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.09050.0862
Sufficiently Up
Slightly volatile
Asset Turnover0.750.4402
Way Up
Slightly volatile
Gross Profit Margin0.40.5528
Way Down
Slightly volatile
Total Current Liabilities1.2 B1.1 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total2.1 B3.4 B
Way Down
Slightly volatile
Total Assets10.9 B10.4 B
Sufficiently Up
Slightly volatile
Total Current Assets4.4 B4.2 B
Sufficiently Up
Slightly volatile
Debt Levels
Hologic can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hologic's financial leverage. It provides some insight into what part of Hologic's total assets is financed by creditors.
Liquidity
Hologic currently holds 2.63 B in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Hologic has a current ratio of 3.82, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Hologic's use of debt, we should always consider it together with its cash and equity.

Total Cash From Operating Activities

1.28 Billion
Hologic (HOLX) is traded on NASDAQ Exchange in USA and employs 7,070 people. Hologic is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 16.63 B. Hologic conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 223.07 M outstanding shares of which 3.67 M shares are currently shorted by private and institutional investors with about 1.24 trading days to cover. Hologic currently holds about 2.39 B in cash with 1.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.59.
Check Hologic Probability Of Bankruptcy
Ownership Allocation
Hologic has a total of 223.07 Million outstanding shares. The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. Also note that almost six hundred fourty-six thousand eight hundred ninety invesors are currently shorting Hologic expressing very little confidence in its future performance.
Check Hologic Ownership Details

Hologic Stock Institutional Holders

InstituionRecorded OnShares
Northern Trust Corp2025-06-30
2.8 M
Arrowstreet Capital Limited Partnership2025-06-30
2.8 M
Norges Bank2025-06-30
2.8 M
Ubs Asset Mgmt Americas Inc2025-06-30
2.6 M
Nordea Investment Mgmt Bank Demark A/s2025-06-30
2.6 M
Dimensional Fund Advisors, Inc.2025-06-30
2.5 M
Morgan Stanley - Brokerage Accounts2025-06-30
2.4 M
Alliancebernstein L.p.2025-06-30
2.2 M
Ameriprise Financial Inc2025-06-30
1.9 M
Vanguard Group Inc2025-06-30
26.8 M
T. Rowe Price Investment Management,inc.2025-06-30
24.1 M
View Hologic Diagnostics

Hologic Historical Income Statement

At this time, Hologic's Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 683.1 M in 2026, whereas Total Other Income Expense Net is likely to drop (31.3 M) in 2026. View More Fundamentals

Hologic Stock Against Markets

Hologic Corporate Management

Mark IrvingVP SecretaryProfile
Paul MalenchiniChief OfficerProfile
Peter DunneSenior ResourcesProfile
Benjamin CohnPrincipal Chief Accounting OfficerProfile
Erik AndersonDivision SolutionsProfile
Kevin ThornalGroup SolutionsProfile

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.